SCHEMBL6169973

SCHEMBL6169973

COC(=O)c1cccc([N+](=O)[O-])c1N(Cc1ccc(Cl)cc1Cl)C(C)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.49
ALDH1A1 P00352 4/20 0.49
LMNA P02545 2/20 0.49
HTT P42858 2/20 0.49
HPGD P15428 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PLA2G1B P04054 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
G6PD P11413 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.40
DHODH Q02127 1/20 0.40
FABP3 P05413 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7479176 0.79 TSHR (0.47) MAPTALDH1A1LMNANPSR1RAB9A
SCHEMBL7590703 0.76 FABP3 (0.44) MAPTALDH1A1LMNAHTTHPGD
SCHEMBL6169967 0.74 MAPT (0.49) MAPTALDH1A1LMNAHTTHPGD
SCHEMBL6299991 0.72 FLT1 (0.43) MAPTALDH1A1LMNAHPGDNPSR1
SCHEMBL6170317 0.71 KMT2A (0.50) MAPTALDH1A1LMNAHTTHPGD
SCHEMBL6300189 0.70 TSHR (0.41) MAPTALDH1A1LMNAHTTHPGD
SCHEMBL1315721 0.69 TDP1 (0.59) MAPTALDH1A1HPGDTDP1NPC1
SCHEMBL544309 0.69 MEN1 (0.56) MAPTALDH1A1LMNATDP1MEN1
SCHEMBL31549875 0.69 TDP1 (0.70) MAPTALDH1A1TDP1MEN1KMT2A
SCHEMBL40265 0.69 TDP1 (0.70) MAPTALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed